ranbaxy laboratories (GoldmanSachs) expectations: Donepezil discount steeper; margins improve

Date Rating Target Price Recommendation Price Broker house
11 May 2011 neutral 481 (from 495) 449 GoldmanSachs Report

No comments:

Post a Comment